Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

5.6K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.6K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

16.0K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
16.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overcoming the challenges of genome-editing essential genes.

STAR protocols·2026
Same author

Improve genetic quality control to increase rigor and reproducibility of mouse research.

Science (New York, N.Y.)·2026
Same author

Modeling patient variants of <i>Cnot1</i> and <i>Cdc42bpb</i> results in distinct forms of congenital diaphragmatic hernia in mice.

bioRxiv : the preprint server for biology·2026
Same author

Data-driven prioritization of mouse strains for improved preclinical modeling of rare and common disease.

bioRxiv : the preprint server for biology·2026
Same author

Evolutionary transfer learning enables organism-wide inference of mammalian enhancer landscapes.

bioRxiv : the preprint server for biology·2026
Same author

Towards clinical translation of nanomedicines: Formulation scale-up and model systems.

Advanced drug delivery reviews·2026

Related Experiment Video

Updated: Jan 18, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

35.5K

Phenotyping first-generation genome editing mutants: a new standard?

Lydia Teboul1, Stephen A Murray2, Patrick M Nolan3

  • 1The Mary Lyon Centre, MRC Harwell Institute, Harwell Science Campus, Didcot, Oxfordshire, UK. l.teboul@har.mrc.ac.uk.

Mammalian Genome : Official Journal of the International Mammalian Genome Society
|July 31, 2017
PubMed
Summary

CRISPR/Cas9 genome engineering enables rapid mutant founder generation for research. However, these first-generation mutants are often genetic mosaics, posing challenges for scientific validity and data interpretation.

More Related Videos

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

8.1K
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.5K

Related Experiment Videos

Last Updated: Jan 18, 2026

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

35.5K
A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins
08:37

A Rapid and Facile Pipeline for Generating Genomic Point Mutants in C. elegans Using CRISPR/Cas9 Ribonucleoproteins

Published on: April 30, 2018

8.1K
Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.5K

Area of Science:

  • Genetics
  • Molecular Biology
  • Bioengineering

Background:

  • The CRISPR/Cas9 system offers high efficiency for genome engineering.
  • Conventional methods for generating phenotyping cohorts involve multi-generational crosses, which are time-consuming.
  • CRISPR/Cas9 technology allows for the creation of mutant founders, potentially accelerating research.

Purpose of the Study:

  • To discuss the benefits of using first-generation CRISPR/Cas9-generated mutant founders.
  • To outline the challenges associated with genetic mosaicism in these mutants.
  • To evaluate the scientific validity of employing such models in research.

Main Methods:

  • Literature review and discussion of CRISPR/Cas9 technology.
  • Analysis of genetic mosaicism in first-generation mutants.
  • Evaluation of research models utilizing mutant founders.

Main Results:

  • First-generation mutants generated by CRISPR/Cas9 can accelerate research by bypassing traditional breeding schemes.
  • These mutants frequently exhibit genetic mosaicism, leading to a complex and undefined genetic makeup.
  • The presence of mosaicism raises questions about the scientific validity and reproducibility of studies using these models.

Conclusions:

  • Mutant founders generated via CRISPR/Cas9 offer a promising avenue for accelerated research.
  • Addressing the challenges of genetic mosaicism is crucial for ensuring the reliability of these models.
  • Further investigation into the scientific validity of mosaic mutant founders is warranted.